Health Outcomes of CAPABLE in Permanent Supportive Housing

November 14, 2026 updated by: Benjamin F. Henwood, University of Southern California

This study will evaluate whether Community Aging in Place-Advancing Better Living for Elders (CAPABLE) improves daily functioning among adults aged 45 years and older who live in permanent supportive housing and have difficulty performing everyday activities.

Participants will be randomly assigned to receive either CAPABLE in addition to their usual services or usual services alone. CAPABLE is a person-directed, home-based program delivered by an occupational therapist and a registered nurse. Participants assigned to CAPABLE may receive up to 10 home visits over approximately six months, including up to six occupational therapy visits and four nursing visits. Assistive devices and minor home modifications may also be provided based on each participant's goals and needs.

The study will enroll approximately 634 participants in Los Angeles County. Researchers will assess participants at enrollment and at 3, 6, 9, and 12 months. The main outcomes are participants' ability to perform activities of daily living and instrumental activities of daily living. The study will also examine health-related quality of life, health care use, housing stability, and the cost-effectiveness of CAPABLE.

Study Overview

Detailed Description

This randomized effectiveness trial will examine the effectiveness and cost-effectiveness of CAPABLE when delivered to adults living in permanent supportive housing. CAPABLE is a person-directed intervention designed to address functional limitations by integrating occupational therapy, nursing, assistive devices, and minor home modifications.

Approximately 634 participants will be randomly assigned in a 1:1 ratio to the CAPABLE intervention group or the usual-care control group. Participants assigned to CAPABLE will receive the intervention in addition to the health and supportive services normally available to them. The intervention may include up to six occupational therapy visits and four registered nursing visits over approximately six months. The occupational therapist and nurse will work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services will be provided when appropriate. Participants assigned to the control group will continue to receive their usual services.

Study assessments will occur at baseline and at 3, 6, 9, and 12 months. Full outcome assessments will be conducted at baseline, 6 months, and 12 months, with shorter assessments of health care utilization and health-related quality of life at 3 and 9 months. The primary outcomes are limitations in activities of daily living and instrumental activities of daily living. Additional outcomes include health-related quality of life, health care utilization, housing stability, and intervention costs.

Outcome assessors will be masked to participants' treatment assignments. The economic evaluation will compare intervention costs with changes in health-related quality of life and health care utilization to estimate the cost-effectiveness of CAPABLE relative to usual care.

Study Type

Interventional

Enrollment (Estimated)

634

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Benjamin F Henwood, PhD, MSW, MA
  • Phone Number: 213-821-0496
  • Email: bhenwood@usc.edu

Study Locations

    • California
      • Los Angeles, California, United States, 90089
        • University of Southern California
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able and willing to provide informed consent
  • Client of the Los Angeles County Department of Health Services
  • Living in permanent supportive housing
  • Age 45 years or older
  • Cognitively intact or experiencing only mild cognitive impairment
  • Proficient in English or Spanish
  • Reports some or a lot of difficulty performing at least one activity of daily living or instrumental activity of daily living

Exclusion Criteria:

  • Does not meet one or more inclusion criteria
  • Unwilling or unable to provide informed consent
  • Withdraws consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CAPABLE

Participants assigned to this arm will receive CAPABLE in addition to their usual health and supportive services. CAPABLE is a person-directed, home-based intervention delivered over approximately six months and may include up to six occupational therapy visits and four registered nursing visits. Assistive devices, minor home modifications, and coordination with existing services may be provided based on each participant's goals and needs.

CAPABLE is a person-directed, home-based behavioral intervention designed to improve participants' ability to perform everyday activities. The intervention is delivered over approximately six months and may include up to six visits from an occupational therapist and four visits from a registered nurse. The occupational therapist and nurse work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services may be provided as appropriate based on each participant's goals and needs.

No Intervention: Usual Care

Participants assigned to this arm will continue to receive the health and supportive services normally available to them and will not receive the CAPABLE intervention during the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Activities of Daily Living Limitations
Time Frame: Baseline, 6 months, and 12 months

Activities of daily living will be assessed using an 8-item scale measuring difficulty with basic daily activities. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.

Baseline, 6 months, and 12 months
Change in Instrumental Activities of Daily Living Limitations
Time Frame: Baseline, 6 months, and 12 months

Instrumental activities of daily living will be assessed using the 8-item Brief Instrumental Functioning Scale. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.

Baseline, 6 months, and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality-Adjusted Life Years
Time Frame: Baseline and 3, 6, 9, and 12 months

Health-related quality of life will be measured using the five-item EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Responses will be converted to health-state utility values and used to calculate quality-adjusted life years over the 12-month follow-up period. Higher quality-adjusted life years indicate better health outcomes.

Baseline and 3, 6, 9, and 12 months
Health Care Utilization
Time Frame: Baseline and 3, 6, 9, and 12 months

Health care utilization during the preceding three months will be assessed using the 12-item UCSD Healthcare Utilization Questionnaire. Participants will report their use of inpatient hospital care, surgery, nursing home care, emergency department care, ambulance services, outpatient health care, home care, telephone or online health care, prescription medications, and over-the-counter medications. Utilization will be compared between study arms and used to estimate health care costs.

Baseline and 3, 6, 9, and 12 months
Incremental Cost-Effectiveness of CAPABLE
Time Frame: From baseline through 12 months

Incremental cost-effectiveness ratios will compare CAPABLE with usual care. Ratios will be calculated by dividing the difference between study arms in intervention and health care costs by the corresponding differences in activities of daily living limitations, instrumental activities of daily living limitations, and quality-adjusted life years. Lower costs per unit of improvement indicate greater cost-effectiveness.

From baseline through 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2027

Primary Completion (Estimated)

August 31, 2029

Study Completion (Estimated)

August 31, 2030

Study Registration Dates

First Submitted

November 9, 2026

First Submitted That Met QC Criteria

November 14, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 14, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A deidentified quantitative individual participant dataset will be shared. The study protocol, survey instruments, and data dictionary will also be made available to facilitate interpretation and reuse of the data. The dataset and associated documentation will be deposited in the National Archive of Computerized Data on Aging (NACDA), which is part of ICPSR.

IPD Sharing Time Frame

The IPD and supporting information will become available following completion of the planned study analyses and no later than August 31, 2031. Materials deposited in NACDA will remain available indefinitely.

IPD Sharing Access Criteria

Researchers will be able to access the deidentified individual participant dataset and supporting documentation through NACDA within ICPSR at no charge. Users must agree to the repository's terms of use, including limiting use to research or statistical purposes, not attempting to identify participants, not redistributing downloaded data, and properly citing the dataset.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe